Sulfur mustard-induced pulmonary injury: Therapeutic approaches to mitigating toxicity

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 1, 2011, Pages 92-99

  Weinberger, Barry ^a   Laskin, Jeffrey D ^b   Sunil, Vasanthi R ^c   Sinko, Patrick J ^c   Heck, Diane E ^d   Laskin, Debra L ^c  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Lung; Sulfur mustard; Toxicity; Vesicants

Indexed keywords

2 CHLOROETHYLETHYLSULFIDE; ACETYLCYSTEINE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; APROTININ; BIOCHEMICAL MARKER; BRONCHODILATING AGENT; CASPASE; CHLORMETHINE; CYTOKINE; DOXYCYCLINE; ILOMASTAT; LUNG SURFACTANT; MACROLIDE; MATRIX METALLOPROTEINASE; MELATONIN; MELPHALAN; METALLOPORPHYRIN; MUSTARD GAS; MUSTARD GAS DERIVATIVE; NITRIC OXIDE SYNTHASE INHIBITOR; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEINASE INHIBITOR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SALBUTAMOL; STEROID; TOCOPHEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASTHMA; AUTOPHAGY; BASEMENT MEMBRANE; BRONCHOSPASM; CELL CULTURE; CELL DISRUPTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; DRUG EFFICACY; DRUG HALF LIFE; ENZYME ACTIVITY; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMIDIFIER; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LUNG; LUNG ALVEOLUS EPITHELIUM; LUNG FUNCTION; LUNG INJURY; LUNG TOXICITY; MEDIATOR; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RESPIRATORY SYSTEM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; HUMANS; LUNG; MODELS, ANIMAL; MUSTARD GAS; PROTEASE INHIBITORS; PULMONARY SURFACTANTS;

EID: 79251593999     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2010.09.004     Document Type: Article

References (102)

1. Dacre J.C., Goldman M. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol Rev 1996, 48:289-326.
2. Kehe K., Thiermann H., Balszuweit F., Eyer F., Steinritz D., Zilker T. Acute effects of sulfur mustard injury-Munich experiences. Toxicology 2009, 263:3-8.
3. Khateri S., Ghanei M., Keshavarz S., Soroush M., Haines D. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 2003, 45:1136-1143.
4. Kehe K., Balszuweit F., Emmler J., Kreppel H., Jochum M., Thiermann H. Sulfur mustard research-strategies for the development of improved medical therapy. Eplasty 2008, 8:e32.
5. Kehe K., Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology 2005, 214:198-209.
6. Sohrabpour H. Clinical manifestations of chemical agents on Iranian combatants during Iran-Iraq conflict. Arch Belg 1984, 291-297.
7. Emad A., Rezaian G.R. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest 1997, 112:734-738.
8. Ghanei M., Akhlaghpoor S., Moahammad M.M., Aslani J. Tracheobronchial stenosis following sulfur mustard inhalation. Inhal Toxicol 2004, 16:845-849.
9. Mirsadraee M., Attaran D., Boskabady M.H., Towhidi M. Airway hyperresponsiveness to methacholine in chemical warfare victims. Respiration 2005, 72:523-528.
10. Rowell M., Kehe K., Balszuweit F., Thiermann H. The chronic effects of sulfur mustard exposure. Toxicology 2009, 263:9-11.
11. Pourfarzam S., Ghazanfari T., Yaraee R., Ghasemi H., Hassan Z.M., Faghihzadeh S., et al. Serum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol 2009, 9:1482-1488.
12. Yaraee R., Ghazanfari T., Faghihzadeh S., Mostafaie A., Soroush M.R., Inai K., et al. Alterations in the serum levels of soluble L, P and E-selectin 20 years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immunopharmacol 2009, 9:1477-1481.
13. Attaran D., Lari S.M., Khajehdaluee M., Ayatollahi H., Towhidi M., Asnaashari A., et al. Highly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseases. Hum Exp Toxicol 2009, 28:739-745.
14. Ghazanfari T., Sharifnia Z., Yaraee R., Pourfarzam S., Kariminia A., Mahlojirad M., et al. Serum soluble Fas ligand and nitric oxide in long-term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol 2009, 9:1489-1493.
15. Emad A., Emad Y. Levels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalation. J Interferon Cytokine Res 2007, 27:38-43.
16. Emad A., Emad Y. Relationship between eosinophilia and levels of chemokines (CCL5 and CCL11) and IL-5 in bronchoalveolar lavage fluid of patients with mustard gas-induced pulmonary fibrosis. J Clin Immunol 2008, 28:298-305.
17. Shohrati M., Ghanei M., Shamspour N., Jafari M. Activity and function in lung injuries due to sulphur mustard. Biomarkers 2008, 13:728-733.
18. Shohrati M, Ghanei M, Shamspour N, Babaei F, Abadi MN, Jafari M, et al. Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication. Lung 188:77-83.
19. Hosseini-khalili A., Haines D.D., Modirian E., Soroush M., Khateri S., Joshi R., et al. Mustard gas exposure and carcinogenesis of lung. Mutat Res 2009, 678:1-6.
20. Pohl C., Hermanns M.I., Uboldi C., Bock M., Fuchs S., Dei-Anang J., et al. Barrier functions and paracellular integrity in human cell culture models of the proximal respiratory unit. Eur J Pharm Biopharm 2009, 72:339-349.
21. Pohl C., Papritz M., Moisch M., Wubbeke C., Hermanns M.I., Uboldi C., et al. Acute morphological and toxicological effects in a human bronchial coculture model after sulfur mustard exposure. Toxicol Sci 2009, 112:482-489.
22. Sourdeval M., Lemaire C., Deniaud A., Taysse L., Daulon S., Breton P., et al. Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis. Apoptosis 2006, 11:1545-1559.
23. Karacsonyi C., Shanmugam N., Kagan E. A clinically relevant in vitro model for evaluating the effects of aerosolized vesicants. Toxicol Lett 2009, 185:38-44.
24. Ray R., Keyser B., Benton B., Daher A., Simbulan-Rosenthal C.M., Rosenthal D.S. Sulfur mustard induces apoptosis in cultured normal human airway epithelial cells: evidence of a dominant caspase-8-mediated pathway and differential cellular responses. Drug Chem Toxicol 2008, 31:137-148.
25. Ray R., Simbulan-Rosenthal C.M., Keyser B.M., Benton B., Anderson D., Holmes W., et al. Sulfur mustard induces apoptosis in lung epithelial cells via a caspase amplification loop. Toxicology 2010, 271:94-99.
26. Steinritz D., Emmler J., Hintz M., Worek F., Kreppel H., Szinicz L., et al. Apoptosis in sulfur mustard treated A549 cell cultures. Life Sci 2007, 80:2199-2201.
27. Korkmaz A., Yaren H., Topal T., Oter S. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch Toxicol 2006, 80:662-670.
28. Korkmaz A., Kunak Z.I., Paredes S.D., Yaren H., Tan D.X., Reiter R.J. The use of melatonin to combat mustard toxicity. Neuro Endocrinol Lett 2008, 29:614-619.
29. Debiak M., Kehe K., Burkle A. Role of poly(ADP-ribose) polymerase in sulfur mustard toxicity. Toxicology 2009, 263:20-25.
30. Kehe K., Balszuweit F., Steinritz D., Thiermann H. Molecular toxicology of sulfur mustard-induced cutaneous inflammation and blistering. Toxicology 2009, 263:12-19.
31. Jan Y.H., Heck D.E., Gray J.P., Zheng H., Casillas R.P., Laskin D.L., et al. Selective targeting of selenocysteine in thioredoxin reductase by the half mustard 2-chloroethyl ethyl sulfide in lung epithelial cells. Chem Res Toxicol 2010, 23:1045-1053.
32. Gray J.P., Mishin V., Heck D.E., Laskin D.L., Laskin J.D. Inhibition of NADPH cytochrome P450 reductase by the model sulfur mustard vesicant 2-chloroethyl ethyl sulfide is associated with increased production of reactive oxygen species. Toxicol Appl Pharmacol 2010, 247:76-82.
33. Gao X., Ray R., Xiao Y., Ray P. Suppression of inducible nitric oxide synthase expression and nitric oxide production by macrolide antibiotics in sulfur mustard-exposed airway epithelial cells. Basic Clin Pharmacol Toxicol 2008, 103:255-261.
34. Seagrave J., Weber W.M., Grotendorst G.R. Sulfur mustard vapor effects on differentiated human lung cells. Inhal Toxicol 2010, 22:896-902.
35. Arroyo C.M., Von Tersch R.L., Broomfield C.A. Activation of alpha-human tumour necrosis factor (TNF-alpha) by human monocytes (THP-1) exposed to 2-chloroethyl ethyl sulphide (H-MG). Hum Exp Toxicol 1995, 14:547-553.
36. Gould N.S., White C.W., Day B.J. A role for mitochondrial oxidative stress in sulfur mustard analog 2-chloroethyl ethyl sulfide-induced lung cell injury and antioxidant protection. J Pharmacol Exp Ther 2009, 328:732-739.
37. Osterlund C., Lilliehook B., Ekstrand-Hammarstrom B., Sandstrom T., Bucht A. The nitrogen mustard melphalan activates mitogen-activated phosphorylated kinases (MAPK), nuclear factor-kappaB and inflammatory response in lung epithelial cells. J Appl Toxicol 2005, 25:328-337.
38. Andrew D.J., Lindsay C.D. Protection of human upper respiratory tract cell lines against sulphur mustard toxicity by glutathione esters. Hum Exp Toxicol 1998, 17:387-395.
39. Lindsay C.D., Hambrook J.L. Diisopropylglutathione ester protects A549 cells from the cytotoxic effects of sulphur mustard. Hum Exp Toxicol 1998, 17:606-612.
40. Rappeneau S., Baeza-Squiban A., Marano F., Calvet J. Efficient protection of human bronchial epithelial cells against sulfur and nitrogen mustard cytotoxicity using drug combinations. Toxicol Sci 2000, 58:153-160.
41. Vijayaraghavan R., Kulkarni A., Pant S.C., Kumar P., Rao P.V., Gupta N., et al. Differential toxicity of sulfur mustard administered through percutaneous, subcutaneous, and oral routes. Toxicol Appl Pharmacol 2005, 202:180-188.
42. Elsayed N.M., Omaye S.T. Biochemical changes in mouse lung after subcutaneous injection of the sulfur mustard 2-chloroethyl 4-chlorobutyl sulfide. Toxicology 2004, 199:195-206.
43. Elsayed N.M., Omaye S.T., Klain G.J., Korte D.W. Free radical-mediated lung response to the monofunctional sulfur mustard butyl 2-chloroethyl sulfide after subcutaneous injection. Toxicology 1992, 72:153-165.
44. Kim Y.B., Lee Y.S., Choi D.S., Cha S.H., Sok D.E. Change in glutathione S-transferase and glyceraldehyde-3-phosphate dehydrogenase activities in the organs of mice treated with 2-chloroethyl ethyl sulfide or its oxidation products. Food Chem Toxicol 1996, 34:259-265.
45. Hambrook J.L., Howells D.J., Schock C. Biological fate of sulphur mustard (1,1′-thiobis(2-chloroethane)): uptake, distribution and retention of 35S in skin and in blood after cutaneous application of 35S-sulphur mustard in rat and comparison with human blood in vitro. Xenobiotica 1993, 23:537-561.
46. Mishra N.C., Rir-sima-ah J., March T., Weber W., Benson J., Jaramillo R., et al. Sulfur mustard induces immune sensitization in hairless guinea pigs. Int Immunopharmacol 2010, 10:193-199.
47. van Helden H.P., Kuijpers W.C., Diemel R.V. Asthma like symptoms following intratracheal exposure of Guinea pigs to sulfur mustard aerosol: therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal Toxicol 2004, 16:537-548.
48. Calvet J.H., Coste A., Levame M., Harf A., Macquin-Mavier I., Escudier E. Airway epithelial damage induced by sulfur mustard in guinea pigs, effects of glucocorticoids. Hum Exp Toxicol 1996, 15:964-971.
49. Calvet J.H., Jarreau P.H., Levame M., D'Ortho M.P., Lorino H., Harf A., et al. Acute and chronic respiratory effects of sulfur mustard intoxication in guinea pig. J Appl Physiol 1994, 76:681-688.
50. Calvet JH, Planus E, Rouet P, Pezet S, Levame M, Lafuma C, et al. Matrix metalloproteinase gelatinases in sulfur mustard-induced acute airway injury in guinea pigs. Am J Physiol 1;276:L754-L762.
51. Guignabert C., Taysse L., Calvet J.H., Planus E., Delamanche S., Galiacy S., et al. Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs. Am J Physiol 2005, 289:L67-L74.
52. Malaviya R., Sunil V., Cervelli J., Anderson D., Holmes W., Conti M., et al. Inflammatory effects of inhaled sulfur mustard in rat lungs. Toxicol Appl Pharmacol 2010, 248:89-99.
53. Anderson D.R., Yourick J.J., Moeller R.B., Petrali J.P., Young G.D. Pathologic changes in rat lungs following acute sulfur mustard inhalation. Inhal Toxicol 1996, 8:285-297.
54. McClintock S.D., Till G.O., Smith M.G., Ward P.A. Protection from half-mustard-gas-induced acute lung injury in the rat. J Appl Toxicol 2002, 22:257-262.
55. Sunil V, Patel K, Shen J, Reimer D, Gao A, Laskin J, et al. Functional and inflammatory alterations in the lung following exposure of rats to nitrogen mustard. Toxicol Appl Pharmacol; 2010 Sep 27 [Epub ahead of print].
56. Veress L.A., O'Neill H.C., Hendry-Hofer T.B., Loader J.E., Rancourt R.C., White C.W. Airway obstruction due to bronchial vascular injury after sulfur mustard analog inhalation. Am J Respir Crit Care Med 2010, [Epub ahead of print]. 10.1164/rccm.200910-1618OC.
57. McClintock S.D., Hoesel L.M., Das S.K., Till G.O., Neff T., Kunkel R.G., et al. Attenuation of half sulfur mustard gas-induced acute lung injury in rats. J Appl Toxicol 2006, 26:126-131.
58. Kumar O., Vijayaraghavan R. Effect of sulphur mustard inhalation exposure on some urinary variables in mice. J Appl Toxicol 1998, 18:257-259.
59. Das S.K., Mukherjee S., Smith M.G., Chatterjee D. Prophylactic protection by N-acetylcysteine against the pulmonary injury induced by 2-chloroethyl ethyl sulfide, a mustard analogue. J Biochem Mol Toxicol 2003, 17:177-184.
60. Shakarjian M.P., Heck D.E., Gray J.P., Sinko P.J., Gordon M.K., Casilas R.P., et al. Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. Toxicol Sci 2010, 114:5-19.
61. Chen Z.H., Kim H.P., Sciurba F.C., Lee S.J., Feghali-Bostwick C., Stolz D.B., et al. Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One 2008, 3:e3316.
62. Ryter S.W., Choi A.M. Autophagy in the lung. Proc Am Thorac Soc 2010, 7:13-21.
63. Anderson D.R., Taylor S.L., Fetterer D.P., Holmes W.W. Evaluation of protease inhibitors and an antioxidant for treatment of sulfur mustard-induced toxic lung injury. Toxicology 2009, 263:41-46.
64. Calvet J.H., D'Ortho M.P., Jarreau P.H., Levame M., Harf A., Macquin-Mavier I. Glucocorticoids inhibit sulfur mustard-induced airway muscle hyperresponsiveness to substance P. J Appl Physiol 1994, 77:2325-2332.
65. Wigenstam E., Rocksen D., Ekstrand-Hammarstrom B., Bucht A. Treatment with dexamethasone or liposome-encapsuled vitamin E provides beneficial effects after chemical-induced lung injury. Inhal Toxicol 2009, 21:958-964.
66. Sunil V, Patel K, Malaviya R, Laskin J, Laskin D. Inflammatory mediator expression in the lung following exposure to the sulfur mustard analog, 2-chloroethyl ethyl sulfide; role of TNFR1. Am J Respir Crit Care Med 2009;179:A5863.
67. Sunil V., Patel K., Shen J., Reimer D., Gow A., Laskin J., et al. Role of reactive nitrogen species in vesicant-induced lung injury and altered lung functioning. Toxicologist 2010, 114:A336.
68. Kabir S.M., Mukherjee S., Rajaratnam V., Smith M.G., Das S.K. Desensitization of beta-adrenergic receptors in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog. J Biochem Mol Toxicol 2009, 23:59-70.
69. Sinha Roy S., Mukherjee S., Kabir S., Rajaratnam V., Smith M., Das S.K. Inhibition of cholinephosphotransferase activity in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog. J Biochem Mol Toxicol 2005, 19:289-297.
70. Allon N., Amir A., Manisterski E., Rabinovitz I., Dachir S., Kadar T. Inhalation exposure to sulfur mustard in the guinea pig model: clinical, biochemical and histopathological characterization of respiratory injuries. Toxicol Appl Pharmacol 2009, 241:154-162.
71. Anderson D.R., Byers S.L., Vesely K.R. Treatment of sulfur mustard (HD)-induced lung injury. J Appl Toxicol 2000, 20(Suppl. 1):S129-S132.
72. Amir A., Chapman S., Kadar T., Gozes Y., Sahar R., Allon N. Sulfur mustard toxicity in macrophages: effect of dexamethasone. J Appl Toxicol 2000, 20(Suppl. 1):S51-S58.
73. Mukhopadhyay S., Hoidal J.R., Mukherjee T.K. Role of TNFalpha in pulmonary pathophysiology. Respir Res 2006, 7:125.
74. Chatterjee D., Mukherjee S., Smith M.G., Das S.K. Signal transduction events in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog. J Biochem Mol Toxicol 2003, 17:114-121.
75. Mukhopadhyay S., Mukherjee S., Smith M., Das S.K. Activation of MAPK/AP-1 signaling pathway in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard gas analog. Toxicol Lett 2008, 181:112-117.
76. Chakrabarti S., Patel K.D. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res 2005, 31:599-621.
77. Mukhopadhyay S., Mukherjee S., Ray B.K., Ray A., Stone W.L., Das S.K. Antioxidant liposomes protect against CEES-induced lung injury by decreasing SAF-1/MAZ-mediated inflammation in the guinea pig lung. J Biochem Mol Toxicol 2010, 24:187-194.
78. Gao X., Ray R., Xiao Y., Ishida K., Ray P. Macrolide antibiotics improve chemotactic and phagocytic capacity as well as reduce inflammation in sulfur mustard-exposed monocytes. Pulm Pharmacol Ther 2010, 23:97-106.
79. Yaren H., Mollaoglu H., Kurt B., Korkmaz A., Oter S., Topal T., et al. Lung toxicity of nitrogen mustard may be mediated by nitric oxide and peroxynitrite in rats. Res Vet Sci 2007, 83:116-122.
80. Ghanei M., Shohrati M., Harandi A.A., Eshraghi M., Aslani J., Alaeddini F., et al. Inhaled corticosteroids and long-acting beta 2-agonists in treatment of patients with chronic bronchiolitis following exposure to sulfur mustard. Inhal Toxicol 2007, 19:889-894.
81. Boskabady M.H., Attaran D., Shaffei M.N. Airway responses to salbutamol after exposure to chemical warfare. Respirology 2008, 13:288-293.
82. Ghanei M., Rajaeinejad M., Motiei-Langroudi R., Alaeddini F., Aslani J. Helium:oxygen versus air:oxygen noninvasive positive-pressure ventilation in patients exposed to sulfur mustard. Heart Lung 2010 May 22, [Epub ahead of print].
83. Gao X., Ray R., Xiao Y., Barker P.E., Ray P. Inhibition of sulfur mustard-induced cytotoxicity and inflammation by the macrolide antibiotic roxithromycin in human respiratory epithelial cells. BMC Cell Biol 2007, 8:17.
84. Ghanei M., Panahi Y., Mojtahedzadeh M., KhaliliAR Aslani J. Effect of gamma interferon on lung function of mustard gas exposed patients, after 15 years. Pulm Pharmacol Ther 2006, 19:148-153.
85. Mukherjee S., Stone W.L., Yang H., Smith M.G., Das S.K. Protection of half sulfur mustard gas-induced lung injury in guinea pigs by antioxidant liposomes. J Biochem Mol Toxicol 2009, 23:143-153.
86. O'Neill H.C., White C.W., Veress L.A., Hendry-Hofer T.B., Loader J.E., Min E., et al. Treatment with the catalytic metalloporphyrin AEOL 10150 reduces inflammation and oxidative stress due to inhalation of the sulfur mustard analog 2-chloroethyl ethyl sulfide. Free Radic Biol Med 2010, 48:1188-1196.
87. Kumar O., Sugendran K., Vijayaraghavan R. Protective effect of various antioxidants on the toxicity of sulphur mustard administered to mice by inhalation or percutaneous routes. Chem Biol Interact 2001, 134:1-12.
88. Mukhopadhyay S., Rajaratnam V., Mukherjee S., Smith M., Das S.K. Modulation of the expression of superoxide dismutase gene in lung injury by 2-chloroethyl ethyl sulfide, a mustard analog. J Biochem Mol Toxicol 2006, 20:142-149.
89. Hoesel L.M., Flierl M.A., Niederbichler A.D., Rittirsch D., McClintock S.D., Reuben J.S., et al. Ability of antioxidant liposomes to prevent acute and progressive pulmonary injury. Antioxid Redox Signal 2008, 10:973-981.
90. Mukhopadhyay S., Mukherjee S., Stone W.L., Smith M., Das S.K. Role of MAPK/AP-1 signaling pathway in the protection of CEES-induced lung injury by antioxidant liposome. Toxicology 2009, 261:143-151.
91. Ghanei M., Shohrati M., Jafari M., Ghaderi S., Alaeddini F., Aslani J. N-acetylcysteine improves the clinical conditions of mustard gas-exposed patients with normal pulmonary function test. Basic Clin Pharmacol Toxicol 2008, 103:428-432.
92. Laskin J., Heck D., Laskin D. Nitric oxide pathways in toxic responses. General and applied toxicology 2010, Wiley-Blackwell, Hoboken, NJ, 425-38. B. Ballantyne, T. Marrs, T. Syversen (Eds.).
93. Ucar M., Korkmaz A., Reiter R.J., Yaren H., Oter S., Kurt B., et al. Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard. Toxicol Lett 2007, 173:124-131.
94. Corbel M., Belleguic C., Boichot E., Lagente V. Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol Toxicol 2002, 18:51-61.
95. Lagente V., Manoury B., Nenan S., Le Quement C., Martin-Chouly C., Boichot E. Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Braz J Med Biol Res 2005, 38:1521-1530.
96. Corbitt C.A., Lin J., Lindsey M.L. Mechanisms to inhibit matrix metalloproteinase activity: where are we in the development of clinically relevant inhibitors?. Recent Pat Anticancer Drug Discov 2007, 2:135-142.
97. Amin A.R., Attur M.G., Thakker G.D., Patel P.D., Vyas P.R., Patel R.N., et al. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci U S A 1996, 93:14014-14019.
98. Raza M., Ballering J.G., Hayden J.M., Robbins R.A., Hoyt J.C. Doxycycline decreases monocyte chemoattractant protein-1 in human lung epithelial cells. Exp Lung Res 2006, 32:15-26.
99. Wasil M., Halliwell B., Moorhouse C.P. Scavenging of hypochlorous acid by tetracycline, rifampicin and some other antibiotics: a possible antioxidant action of rifampicin and tetracycline?. Biochem Pharmacol 1988, 37:775-778.
100. Gregory T.J., Steinberg K.P., Spragg R., Gadek J.E., Hyers T.M., Longmore W.J., et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997, 155:1309-1315.
101. Randolph A.G. Management of acute lung injury and acute respiratory distress syndrome in children. Crit Care Med 2009, 37:2448-2454.
102. Restrepo R.D. A stepwise approach to management of stable COPD with inhaled pharmacotherapy: a review. Respir Care 2009, 54:1058-1081.